Stephen H. Leech
- Transplantation top 10%
- Renal Transplantation Outcomes and Treatments 4
- Hematology top 10%
- Multiple Myeloma Research and Treatments 4
- Iron Metabolism and Disorders 3
-
- Complement system in diseases 3
-
- Chronic Lymphocytic Leukemia Research 2
-
- Pneumocystis jirovecii pneumonia detection and treatment 2
-
- Occupational exposure and asthma 2
-
- Venous Thromboembolism Diagnosis and Management 2
- Co-authors
- Christopher BryanPrem KumarBrian E. BozelkaRobert L. MarierRobert C. ElstonNathan I. ShapiroKatherine L. HeilpernDavid J. Karras
- Partner nations
- United StatesEgyptFrance
In The Last Decade
Stephen H. Leech
27 papers receiving 297 citations
Peers
Comparison fields: 5 of 80
- Transplantation 34
- Hematology 92
- Parasitology 17
- Immunology 51
- Genetics 25
Countries citing papers authored by Stephen H. Leech
This map shows the geographic impact of Stephen H. Leech's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen H. Leech with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen H. Leech more than expected).
Fields of papers citing papers by Stephen H. Leech
This network shows the impact of papers produced by Stephen H. Leech. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen H. Leech. The network helps show where Stephen H. Leech may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Stephen H. Leech, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Development and validation of a prognostic tool: Pulmonary embolism short-term clinical outcomes risk estimation (PE-SCORE) | 2021 | 0 |
| 2 | Targeting alloantibody production with bortezomib: does it make more sense? | 2010 | 1 |
| 3 | 2009 | 11 | |
| 4 | Risk of thrombogenicity among nonionic radiocontrast agents. | 2008 | 5 |
| 5 | 2005 | 27 | |
| 6 | 2003 | 27 | |
| 7 | 1998 | 21 | |
| 8 | 1992 | 8 | |
| 9 | 1991 | 12 | |
| 10 | 1985 | 7 | |
| 11 | 1984 | 12 | |
| 12 | 1983 | 19 | |
| 13 | 1982 | 4 | |
| 14 | 1982 | 1 | |
| 15 | 1981 | 2 | |
| 16 | 1981 | 3 | |
| 17 | 1981 | 21 | |
| 18 | 1980 | 22 | |
| 19 | 1980 | 7 | |
| 20 | 1972 | 22 |
About Stephen H. Leech
Stephen H. Leech is a scholar working on Transplantation, Hematology and Internal Medicine, having authored 29 papers that have together received 326 indexed citations. Recurring topics across this work include Renal Transplantation Outcomes and Treatments (4 papers), Multiple Myeloma Research and Treatments (4 papers), Complement system in diseases (3 papers), Iron Metabolism and Disorders (3 papers), Chronic Lymphocytic Leukemia Research (2 papers), Pneumocystis jirovecii pneumonia detection and treatment (2 papers), Occupational exposure and asthma (2 papers) and Venous Thromboembolism Diagnosis and Management (2 papers). The work is most often cited by research in Transplantation (34 citations), Hematology (92 citations) and Parasitology (17 citations). Stephen H. Leech has collaborated with scholars based in United States, Egypt and France. Frequent co-authors include Christopher Bryan, Prem Kumar, Brian E. Bozelka, Robert L. Marier, Robert C. Elston, Nathan I. Shapiro, Katherine L. Heilpern, David J. Karras, Khaled Zalata and Howard J. Eisen. Their work appears in journals such as Cancer, Cellular Immunology, Journal of Leukocyte Biology, Gerontology and Annals of Internal Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.